Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary M. Moran
Mary M. Moran
Pfizer
Medicine
Vaccination
Kidney disease
Malignancy
Antimetabolite
4
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
2021
medRxiv
Manuela Di Fusco
Mary M. Moran
Alejandro Cané
Daniel Curcio
Farid Khan
Deepa Malhotra
Andy Surinach
Amanda Miles
David L Swerdlow
John M. McLaughlin
Jennifer L. Nguyen
Show All
Source
Cite
Save
Citations (1)
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
2021
Journal of Medical Economics
Manuela Di Fusco
Mary M. Moran
Alejandro Cané
Daniel Curcio
Farid Khan
Deepa Malhotra
Andy Surinach
Amanda Miles
David L Swerdlow
John M. McLaughlin
Jennifer L. Nguyen
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence
2020
Human Vaccines & Immunotherapeutics
Erica Chilson
Daniel A. Scott
Beate Schmoele-Thoma
Wendy Jo Watson
Mary M. Moran
Raul E. Isturiz
Show All
Source
Cite
Save
Citations (2)
Meningococcal vaccination: A discussion with all adolescents, whether college-bound or not
2019
Postgraduate Medicine
Justine Alderfer
Mary M. Moran
Amit Srivastava
Raul E. Isturiz
Show All
Source
Cite
Save
Citations (0)
1